These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38071966)

  • 1. Diagnostic Precision or Pitfalls: How to Apply the New Acute Myeloid Leukemia Classification Systems?
    Carlson KS; Cunningham A; Stahl M; Winer E; Michaelis LC
    Acta Haematol; 2024; 147(2):122-132. PubMed ID: 38071966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new diagnostic criteria for myelodysplasia-related acute myeloid leukemia is useful for predicting clinical outcome: comparison of the 4th and 5th World Health Organization classifications.
    Park HS; Kim HK; Kim HS; Yang Y; Han HS; Lee KH; Son BR; Kwon J
    Ann Hematol; 2022 Dec; 101(12):2645-2654. PubMed ID: 36220882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the International Consensus Classification and World Health Organization 5th edition classification to a series of myeloid neoplasms.
    Chopra S; Bailey NG
    Am J Clin Pathol; 2023 Dec; 160(6):566-570. PubMed ID: 37587830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical considerations in clinical application of WHO 5th and ICC classification schemes for acute myeloid leukemia.
    Chandra DJ; Lachowiez CA; Loghavi S
    Blood Rev; 2024 Mar; 64():101156. PubMed ID: 38040614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reporting bone marrow biopsies for myelodysplastic neoplasms and acute myeloid leukaemia incorporating WHO 5th edition and ICC 2022 classification systems: ALLG/RCPA joint committee consensus recommendations.
    Ng AP; Adams R; Tiong IS; Seymour L; Talaulikar D; Palfreyman E; Enjeti A; Tate C
    Pathology; 2024 Jun; 56(4):459-467. PubMed ID: 38580613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia.
    Falini B; Martelli MP
    Am J Hematol; 2023 Mar; 98(3):481-492. PubMed ID: 36606297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of WHO-5 and ICC classifications in a series of myeloid neoplasms, considerations for hematopathologists and molecular pathologists.
    Moore ME; Williams E; Pelkey L; Courville EL
    Cancer Genet; 2024 Aug; 286-287():25-28. PubMed ID: 38964162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The International Consensus Classification of acute myeloid leukemia.
    Weinberg OK; Porwit A; Orazi A; Hasserjian RP; Foucar K; Duncavage EJ; Arber DA
    Virchows Arch; 2023 Jan; 482(1):27-37. PubMed ID: 36264379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AML classification in the year 2023: How to avoid a Babylonian confusion of languages.
    Huber S; Baer C; Hutter S; Dicker F; Meggendorfer M; Pohlkamp C; Kern W; Haferlach T; Haferlach C; Hoermann G
    Leukemia; 2023 Jul; 37(7):1413-1420. PubMed ID: 37120689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A practical approach on the classifications of myeloid neoplasms and acute leukemia: WHO and ICC.
    Xiao W; Nardi V; Stein E; Hasserjian RP
    J Hematol Oncol; 2024 Jul; 17(1):56. PubMed ID: 39075565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is new in acute myeloid leukemia classification?
    Park HS
    Blood Res; 2024 Apr; 59(1):15. PubMed ID: 38616211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting.
    Attardi E; Savi A; Borsellino B; Piciocchi A; Cipriani M; Ottone T; Fabiani E; Divona M; Travaglini S; Pascale MR; Awada H; Durmaz A; Visconte V; Della Porta MG; Venditti A; Maciejewski JP; Gurnari C; Voso MT
    Blood Adv; 2023 Sep; 7(17):5122-5131. PubMed ID: 37327116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A real-world analysis of clinical outcomes in AML with myelodysplasia-related changes: a comparison of ICC and WHO-HAEM5 criteria.
    Zhou Q; Zhao D; Zarif M; Davidson MB; Minden MD; Tierens A; Yeung YWT; Wei C; Chang H
    Blood Adv; 2024 Apr; 8(7):1760-1771. PubMed ID: 38286462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The International Consensus Classification of myelodysplastic syndromes and related entities.
    Hasserjian RP; Orazi A; Orfao A; Rozman M; Wang SA
    Virchows Arch; 2023 Jan; 482(1):39-51. PubMed ID: 36287260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controversies in the recent (2016) World Health Organization classification of acute myeloid leukemia.
    Hasserjian RP
    Best Pract Res Clin Haematol; 2021 Mar; 34(1):101249. PubMed ID: 33762104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new WHO and ICC classification systems for myelodysplastic syndromes and their impact on the clinical laboratory.
    Bruehl FK; Osman MM; Chen D; Dalland JC
    J Hematop; 2023 Jun; 16(2):65-71. PubMed ID: 38175439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances towards genome-based acute myeloid leukemia classification: A comparative analysis of WHO-HAEM4R, WHO-HAEM5, and International Consensus Classification.
    Chen X; Yuan L; Zhang Y; Wang F; Ma X; Fang J; Cao P; Liu Y; Liu Z; Liu M; Chen J; Zhou X; Liu M; Jin D; Wang T; Lu P; Liu H
    Am J Hematol; 2024 May; 99(5):824-835. PubMed ID: 38321864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissue: Myeloid Neoplasms.
    Loghavi S; Kanagal-Shamanna R; Khoury JD; Medeiros LJ; Naresh KN; Nejati R; Patnaik MM;
    Mod Pathol; 2024 Feb; 37(2):100397. PubMed ID: 38043791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetics in the management of acute myeloid leukemia and histiocytic/dendritic cell neoplasms: Guidelines from the Groupe Francophone de Cytogénétique Hématologique (GFCH).
    Bidet A; Quessada J; Cuccuini W; Decamp M; Lafage-Pochitaloff M; Luquet I; Lefebvre C; Tueur G;
    Curr Res Transl Med; 2023; 71(4):103421. PubMed ID: 38016419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetics and molecular genetics of myelodysplastic neoplasms.
    Ning Y; Zhang Y; Kallen MA; Emadi A; Baer MR
    Best Pract Res Clin Haematol; 2023 Dec; 36(4):101512. PubMed ID: 38092472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.